CannaPharmaRX appoints Dean Medwid as CEO; Dominic Colvin steps down

CANNAPHARMARX, INC.

Dominic Colvin stepped down as CEO effective June 1, 2023; no disagreement over operations.
Dean Medwid appointed CEO effective June 1, 2023; base salary of CDN $17,325/month plus bonus.
Medwid has 30+ years experience, previously President of New Leaf Ventures, a cannabis company.
Colvin will remain with the company providing 'leadership and vision.'
No family relationships or material interests between Medwid and other officers/directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dean Medwid

Chief Executive Officer

CPMD · CANNAPHARMARX, INC.

Effective: 2023-06-01
Filed: June 23, 2023, 7:59 PM ET

On June 1, 2023, the Company’s Board of Directors appointed Dean Medwid as Chief Executive Officer.

Departed

Dominic Colvin

Chief Executive Officer

CPMD · CANNAPHARMARX, INC.

Effective: 2023-06-01
Successor: Dean Medwid
Filed: June 23, 2023, 7:59 PM ET

Dominic Colvin stepped down as the Chief Executive Officer (“CEO”) of CannPharmaRX, Inc. (the “Company”) effective June 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dean Medwid was appointed as Chief Executive Officer at CANNAPHARMARX, INC..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On June 1, 2023, the Company’s Board of Directors appointed Dean Medwid as Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Dominic Colvin departed as Chief Executive Officer at CANNAPHARMARX, INC..

Action: stepped down
Role: Chief Executive Officer

Exact text from the filing

Dominic Colvin stepped down as the Chief Executive Officer (“CEO”) of CannPharmaRX, Inc. (the “Company”) effective June 1, 2023.

View on SEC.gov

CANNAPHARMARX, INC. filing history →

Source: SEC EDGAR

accession 0001683168-23-004371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.